EXPLANATORY STATEMENT
Supply Act (No. 2) 2020‑2021
AFM Determination (No. 4 of 2020‑2021)
Purpose of this Determination
The Advance to the Finance Minister (AFM) is provided under subsection 12(2) of Supply Act (No. 2) 2020‑2021 (the Act). Section 12 provides that amounts can be allocated from the AFM, up to a limit of $24,000 million. This AFM provision is reduced by the value of AFMs issued under Appropriation Act (No. 6) 2019‑2020. As one allocation was made from Appropriation Act (No. 6) 2019‑2020 for $91.5 million and one allocation was made from Supply Act (No. 2) 2020‑2021 for $250.0 million, the amount available for allocation from Supply Act (No. 2) 2020‑2021 is $23,658.5 million. The Finance Minister must, however, be satisfied there is an urgent need for expenditure, in the current year, that is not provided for, or is insufficiently provided for, in Schedule 2 of the Act, for one of the reasons specified in paragraphs 12(1)(a) and (b).
The Finance Minister is satisfied, based on information provided by the Department of Health (Health) that the additional expenditure was unforeseen until after the last day on which it was practicable to provide for it in Supply Bill (No. 2) 2020‑2021 (the Bill), before it was introduced into the House of Representatives. The Bill was introduced into the House of Representatives on Monday, 23 March 2020. An explanation of the additional expenditure is provided in this determination under the heading ‘Consultation and Impact’ below.
Consistent with paragraph 12(1)(b) of the Act, funding is urgent because the timing for the expenditure was unforeseen when it was last possible to include funding in appropriation legislation before the end of the financial year.
The effect of the determination is that Schedule 2 of Supply Act (No. 2) 2020‑2021 will have effect as if it were amended as specified in the determination.
Advances to the Finance Minister generally
The section providing for the AFM is contained in the annual Appropriation Acts. It enables the Finance Minister to facilitate urgent and unforeseen expenditure that was not within the contemplation of Parliament when the relevant Appropriation Act was passed, and was therefore not provided for in Schedule 1 of the Appropriation Act.
A determination made under subsection 12(2) of Supply Act (No. 2) 2020‑2021 is a legislative instrument, but neither section 42 (disallowance) nor Part 4 of Chapter 3 (sunsetting) of the Legislation Act 2003 applies to the determination.
Statement of Compatibility with Human Rights
Annual Appropriation Acts perform an important constitutional function, by authorising the withdrawal of money from the Consolidated Revenue Fund for the broad purposes identified in the annual Appropriation Acts.
However, as the High Court has emphasised, beyond this, the annual Appropriation Acts do not create rights and nor do they, importantly, impose any duties.
Given that the legal effect of annual Appropriation Acts is limited in this way, the increase of amounts in the annual Appropriation Acts through an AFM is not seen as engaging, or otherwise affecting, the rights or freedoms relevant to the Human Rights (Parliamentary Scrutiny) Act 2011.
Consultation and Impact
Consistent with Part 1 of the Legislation Act 2003, Health was consulted in the preparation of this Determination.
The instrument determines that, in Supply Act (No. 2) 2020‑2021, the Administered Assets and Liabilities for Health is increased by $384,060,000.
This Advance is provided to enable Health to fund the procurement of personal protective equipment and other essential medical supplies and equipment for the National Medical Stockpile to address the unforeseen scale of the COVID-19 spread across the globe.
Overview
The Supply Act (No. 2) 2020-2021, enacted in 2020, addresses the urgent and unforeseen expenditure needs arising from the COVID-19 pandemic that were not accounted for in the initial appropriation legislation. This Act was introduced by the Australian Parliament to provide the necessary financial flexibility to respond to the unprecedented global health crisis, ensuring that the government could swiftly allocate resources to combat the spread of the virus and protect public health. The policy objective of this legislation is to enable the Finance Minister to make immediate allocations from the Advance to the Finance Minister (AFM) when there is an urgent need for expenditure that could not be anticipated at the time of drafting the Supply Bill. The explanatory statement highlights that the additional expenditure is critical for procuring essential medical supplies and equipment, underscoring the necessity for rapid financial response mechanisms in extraordinary circumstances.
Scope and Application
The Supply Act (No. 2) 2020-2021 and the associated AFM Determination (No. 4 of 2020-2021) govern the allocation of funds through the Advance to the Finance Minister (AFM) mechanism. This Act applies to the Commonwealth of Australia and is specifically directed towards the Finance Minister, who is authorised to allocate funds under the AFM to address urgent and unforeseen expenditures not provided for in the appropriations schedules. The determination allows for an allocation of up to $24 billion, with the current available amount set at $23,658.5 million, following certain prior allocations. The AFM is intended to support urgent needs identified by government departments, such as the Department of Health, in this instance for the procurement of personal protective equipment and other essential medical supplies to address the COVID-19 pandemic. The Act does not apply to any other entities or individuals outside the scope of the Finance Minister's authority to allocate AFM funds, and no specific exclusions or exemptions are stated beyond the statutory constraints on the use of AFM provisions. The geographic reach of this legislation is limited to the national level, operating within the framework of Commonwealth legislation.
Key Provisions
The Supply Act (No. 2) 2020-2021, particularly through subsection 12(2), provides for an Advance to the Finance Minister (AFM) of up to $24,000 million, adjusted for previous allocations under the Appropriation Act (No. 6) 2019-2020. Currently, the available amount for allocation from the Supply Act (No. 2) 2020-2021 stands at $23,658.5 million, following allocations of $91.5 million and $250.0 million respectively from the earlier Appropriation Act and the Supply Act itself. The Finance Minister may allocate funds from the AFM if there is an urgent need for expenditure that was not or is insufficiently provided for in Schedule 2 of the Act, for reasons specified in paragraphs 12(1)(a) and (b). Such allocations are permissible if the expenditure is unforeseen and necessary within the current year, a condition satisfied in this instance by information from the Department of Health (Health).
The Act imposes specific obligations on the Finance Minister to ensure that the urgent and unforeseen nature of the expenditure is verified, based on credible and timely information provided by relevant government departments, such as Health. The Minister must also ensure that the expenditure falls within the allowable limits and that it addresses an urgent need that could not be reasonably anticipated when the Supply Bill (No. 2) 2020-2021 was introduced into the House of Representatives on 23 March 2020. This determination is instrumental in allowing the Act to operate as if amended, reflecting the need for flexibility in funding critical areas like the procurement of personal protective equipment and other essential medical supplies and equipment.
The legislation does not specify offences or penalties for breach within the AFM provision itself, but any misuse or misallocation of funds could potentially lead to broader legal consequences under other provisions of the Supply Act or related financial management regulations. The AFM provision is designed to ensure that urgent, unforeseen expenditures are met without the need for additional parliamentary approval, thus facilitating prompt action in times of crisis. The legal instrument is exempt from certain legislative scrutiny processes such as disallowance and sunsetting as per the Legislation Act 2003.
The compatibility of this AFM provision with human rights is upheld as the High Court has noted that annual Appropriation Acts do not create rights or impose duties beyond the authorisation of withdrawals from the Consolidated Revenue Fund. Consequently, the increase of amounts through an AFM does not engage or affect relevant human rights or freedoms as stipulated under the Human Rights (Parliamentary Scrutiny) Act 2011. This determination was prepared in consultation with Health, aligning with the legislative requirement under Part 1 of the Legislation Act 2003. The specific allocation of $384,060,000 to Health is intended to address the unforeseen scale of the COVID-19 pandemic by funding essential supplies for the National Medical Stockpile.